Lipocine Inc. (LPCN)
NASDAQ: LPCN · Real-Time Price · USD
7.34
-0.71 (-8.82%)
At close: Mar 13, 2026, 4:00 PM EDT
7.89
+0.55 (7.49%)
After-hours: Mar 13, 2026, 7:53 PM EDT
Lipocine Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Lipocine stock has a target of 15, which predicts a 104.36% increase from the current stock price of 7.34.
Price Target: $15 (+104.36%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Jan 21, 2026.
Analyst Ratings
According to 1 stock analyst, the rating for Lipocine is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $7 → $15 | Strong Buy | Maintains | $7 → $15 | +104.36% | Jan 21, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $8 → $7 | Strong Buy | Maintains | $8 → $7 | -4.63% | Nov 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +8.99% | Aug 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +8.99% | Jun 27, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +8.99% | Jun 10, 2025 |
Financial Forecast
Revenue This Year
637.50K
from 1.98M
Decreased by -67.75%
Revenue Next Year
1.11M
from 637.50K
Increased by 74.43%
EPS This Year
-1.85
from -1.77
EPS Next Year
-1.07
from -1.85
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 892,500 | 1.1M | |||
| Avg | 637,500 | 1.1M | |||
| Low | 392,000 | 1.1M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -54.8% | 79.6% | |||
| Avg | -67.7% | 74.4% | |||
| Low | -80.2% | 67.5% |
EPS Forecast
| EPS | 2026 | 2027 |
|---|---|---|
| High | -1.42 | -1.10 |
| Avg | -1.85 | -1.07 |
| Low | -2.22 | -1.03 |
EPS Growth
| EPS Growth | 2026 | 2027 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.